Reduced plasma fetuin-A levels in patients with obstructive sleep apnoea

European Respiratory Journal

Volumn 40, Issue 4, 2012, Pages 1046-1048

  Barceló, Antonia ^a,b   Piérola, Javier ^a,b   Esquinas, Cristina ^c   De La Peña, Mónica ^a,b   Arqué, Meritxell ^a   Sánchez De La Torre, Manuel ^b,c   Alonso Fernandez, Alberto ^a,b   Barbé, Ferran ^b,c  

^a HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FETUIN A; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE;

ADULT; APNEA HYPOPNEA INDEX; AROUSAL; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SLEEP DISORDERED BREATHING;

ADULT; ALPHA-2-HS-GLYCOPROTEIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; SLEEP APNEA, OBSTRUCTIVE; VASCULAR CALCIFICATION;

EID: 84867136904     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00011912     Document Type: Letter

References (20)

1. Marin JM, Carrizo SJ, Vicente E, et al. Long term cardiovascular outcomes in men with obstructive sleep apnea. Effects of treatment with CPAP. Lancet 2005; 365: 1046-1053.
2. Pack AI, Gislason T. Obstructive sleep apnea and cardiovascular disease: a perspective and future directions. Prog Cardiovasc Dis 2009; 51: 434-451.
3. Demer LL, Tintut Y. Vascular calcification: pathobiology of a multifaceted disease. Circulation 2008; 117: 2938-2948. (Pubitemid 351787058)
4. Sage AP, Tintut Y, Demer LL. Regulatory mechanisms in vascular calcification. Nat Rev Cardiol 2010; 7: 528-536.
5. Schindler TH, Cadenas J, Facta AD, et al. Improvement in coronary endothelial function is independently associated with a slowed progression of coronary artery calcification in type 2 diabetes mellitus. Eur Heart J 2009; 30: 3064-3073.
6. Abedin M, Tintut Y, Demer LL. Vascular calcification: mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol 2004; 24: 1161-1170. (Pubitemid 38880003)
7. Lim P, Collet JP, Moutereau S, et al. Fetuin-A is an independent predictor of death after ST-elevation myocardial infarction. Clin Chem 2007; 53: 1835-1840. (Pubitemid 47509678)
8. Rezg R, Barreto FC, Barreto DV, et al. Inhibitors of vascular calcification as potential therapeutic targets. J Nephrol 2011; 24: 416-427.
9. Schafer C, Heiss A, Schwarz A, et al. The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 2003; 112: 357-366. (Pubitemid 38063764)
10. Jahnen-Dechent W, Heiss A, Schafer C, et al. Fetuin-A regulation of calcified matrix metabolism. Circ Res 2011; 108: 1494-1509.
11. Bilgir O, Kebapcilar L, Bilgir F, et al. Decreased serum fetuin-A levels are associated with coronary artery diseases. Intern Med 2010; 49: 1281-1285.
12. Roos M, von Eynatten M, Heemann U, et al. Serum fetuin-A, cardiovascular risk factors, and six-year follow-up outcome in patients with coronary heart disease. Am J Cardiol 2010; 105: 1666-1672.
13. Ix JH, Shlipak MG, Brandenburg VM, et al. Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study. Circulation 2006; 113: 1760-1767. (Pubitemid 43958469)
14. National Institutes of Health. Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Bethesda, National Institutes of Health 2001. NIH Publication 01-3670.
15. Suliman ME, Garcia-Lopez E, Anderstam B, et al. Vascular calcification inhibitors in relation to cardiovascular disease with special emphasis on fetuin-A in chronic kidney disease. Adv Clin Chem 2008; 46: 217-262.
16. Tsirpanlis G. Is inflammation the link between atherosclerosis and vascular calcification in chronic kidney disease? Blood Purif 2007; 25: 179-182. (Pubitemid 46447077)
17. Giachelli CM. Vascular calcification mechanisms. J Am Soc Nephrol 2004; 15: 2959-2964. (Pubitemid 39578826)
18. Olson JC, Edmundowicz D, Becker DJ, et al. Coronary calcium in adults with type 1 diabetes: a stronger correlate of clinical coronary artery disease in men than in women. Diabetes 2000; 49: 1571-1578.
19. London GM, Guerin AP, Marchais SJ, et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003; 18: 1731-1740. (Pubitemid 37098542)
20. Ketteler M, Bongartz P, Westenfeld R, et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 2003; 361: 827-833. (Pubitemid 36331846)